Drug Type Small molecule drug |
Synonyms Sulbencillin Sodium, Sulbenicillin, Sulbenicillin sodium (JP17) + [2] |
Target |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (10 Aug 1972), |
Regulation- |
Molecular FormulaC16H18N2NaO7S2 |
InChIKeyDGMOWYXFFHYUJF-MTAVSQAGSA-N |
CAS Registry28002-18-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01489 | Sulbenicillin Sodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Complicated skin and soft tissue infection | CN | 01 Jan 1985 | |
Pneumonia | CN | 01 Jan 1985 | |
Sepsis | CN | 01 Jan 1985 | |
Urinary Tract Infections | CN | 01 Jan 1985 | |
Bacterial Infections | JP | 10 Aug 1972 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Intraabdominal Infections | Phase 1 | CN | 17 Jul 2019 | |
Intraabdominal Infections | Phase 1 | CN | 17 Jul 2019 | |
Pelvic Infection | Phase 1 | CN | 17 Jul 2019 | |
Pelvic Infection | Phase 1 | CN | 17 Jul 2019 | |
Soft Tissue Infections | Phase 1 | CN | 17 Jul 2019 | |
Soft Tissue Infections | Phase 1 | CN | 17 Jul 2019 |